AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
15min chapter
Mission-Driven Dementia Funding with DDF's Jonathan Behr
Business Of Biotech
Challenges and Successes in Developing Disease-Modifying Drugs for Cognitive Disorders
The chapter delves into the obstacles and achievements in creating disease-modifying medications for cognitive disorders such as Alzheimer's disease. It reflects on the historical disparity in drug approvals between areas like oncology and cognitive disorders, recent advancements in drug approvals, and the impact on drug development perceptions. The conversation emphasizes the significance of balancing short-term factors like investment appeal with long-term considerations for patient needs and the drug development pipeline.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode